TNF and thyroid cancer: A similar pattern was observed in the general Korean population, with thyroid cancer being the most frequent malignancy in individuals aged <40 years and lung cancer in those aged ≥40 years, consistent with our AS cohort receiving TNF inhibitors (Supplementary Table S1) [30].